OakChart

Replimune Group Inc

REPLHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 8:19 AM ET

23.65+0.37 (1.59%)
2026-11-11 14:41 CET
Market cap
2,206.95 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-271.03 USD m
Free cash flow, TTM
-245.77 USD m
EPS diluted, TTM
-2.92
P/E
-
Compare

Price

REPL against its 20, 50 and 200-day averages
2050200beatmiss
5.0010.0015.0020.0025.0025.7M51.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26REPLclose 23.6520-day 16.4250-day 14.55200-day 9.8723.65

1.5% under 24.02 on 11 Nov 2026. Last 15 sessions, 111.5% high to low

Profile

REPL
52-week range, 100% of the way up
1.5023.41

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

IndexRUT
Employees465
IPOJul 20, 2018
Beta0.88
ATR, 14d1.24
Rel volume0.02
Short float27.60%
Insider own5.95%
Inst own105.79%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.24B
Enterprise Value2.06B
Income-271.03M
Sales0.00M
Book/sh2.16
Cash/sh3.25
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees465
IPOJul 20, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B10.95
P/C7.28
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio6.90
Current Ratio7.11
Debt/Eq0.62
LT Debt/Eq0.60
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.92
EPS next Y-1.36
EPS next Q-0.58
EPS this Y31.74%
EPS next Y41.10%
EPS next 5Y-
EPS past 3/5Y-4.15% -14.11%
Sales past 3/5Y- -
EPS Y/Y TTM19.12%
Sales Y/Y TTM-
EPS Q/Q39.93%
Sales Q/Q-
EarningsOct 28 BMO
EPS/Sales Surpr.31.12% -

Ownership

Insider Own5.95%
Insider Trans-3.61%
Inst Own105.79%
Inst Trans15.21%
ROA-71.01%
ROE-115.80%
ROIC-82.65%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2043.99%
SMA5062.56%
SMA200139.71%
Trades-

Technical

Shs Outstand94.81M
Shs Float89.16M
Short Float27.60%
Short Ratio9.11
Short Interest24.61M
52W High23.41 1.03%
52W Low1.50 1476.67%
Volatility6.10% 8.55%
ATR (14)1.24
RSI (14)83.45
Beta0.88
Rel Volume0.02
Avg Volume2.70M
Volume2,293

Performance

Perf Week14.31%
Perf Month95.29%
Perf Quarter55.69%
Perf Half Y346.23%
Perf YTD143.31%
Perf Year159.04%
Perf 3Y112.87%
Perf 5Y-29.84%
Perf 10Y-
Recom1.00
Target Price24.17
Prev Close23.28
Price23.65
Change %1.59%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 07, 2026UpgradeWWedbushNeutral → Outperform$12-49.3%
Aug 04, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$17-28.1%
Jul 31, 2026UpgradeWWedbushNeutral → Outperform$12-49.3%
Jul 31, 2026UpgradeCCantor FitzgeraldNeutral → Overweight
Jun 30, 2026UpgradeBBMO Capital MarketsUnderperform → Outperform$16-32.3%
Jun 26, 2026UpgradeJJP MorganNeutral → Overweight$17-28.1%
May 29, 2026UpgradeJJP MorganUnderweight → Neutral$8-66.2%
Apr 13, 2026DowngradeWWedbushOutperform → Neutral$2-91.5%
Apr 13, 2026DowngradeLLeerink PartnersOutperform → Market Perform$2-91.5%
Apr 13, 2026DowngradeJJP MorganNeutral → Underweight

Peers

Mkt cap
TickerCompanyMkt cap
CADLCandel Therapeutics Inc723.10M
IOVAIovance Biotherapeutics Inc3.80B
IMCRImmunocore Holdings plc ADR1.67B
CGONCg Oncology Inc6.61B
GNLXGenelux Corp88.23M
ONCYOncolytics Biotech Inc48.64M
KRYSKrystal Biotech Inc9.07B
MRNAModerna Inc103.08B
ELTXElicio Therapeutics Inc45.57M
CLLSCellectis ADR93.31M

Insider trading

latest 14 of 29
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
SLATTERY JOSEPH PDirectorNov 09 '26Sale21.805,200113,3601,467Nov 10 04:30 PM
JOSEPH P SLATTERYDirectorNov 09 '26Proposed Sale21.805,200113,360Nov 09 05:35 PM
Dhingra KapilDirectorNov 02 '26Option Exercise1.7543,16975,54643,169Nov 03 08:43 PM
Dhingra KapilDirectorNov 02 '26Sale19.0021,500408,50021,669Nov 03 08:43 PM
PAOLO PUCCIDirectorNov 03 '26Proposed Sale20.43138,7002,833,988Nov 03 04:29 PM
Kapil DhingraDirectorNov 02 '26Proposed Sale17.7516,500292,875Nov 02 04:08 PM
VELEKA PEEPLES-DYERDirectorOct 30 '26Proposed Sale16.7210,000167,232Oct 30 04:34 PM
VELEKA PEEPLES-DYERDirectorOct 28 '26Proposed Sale12.9012,000154,745Oct 28 04:02 PM
Hill Emily LuisaChief Financial OfficerAug 17 '26Sale14.289,256132,176215,852Aug 19 06:42 PM
Patel SushilChief Executive OfficerAug 10 '26Sale12.9739,341510,253708,151Aug 12 05:07 PM
Hill Emily LuisaChief Financial OfficerAug 10 '26Sale12.9711,448148,481225,108Aug 12 05:06 PM
Xynos KonstantinosChief Medical OfficerAug 10 '26Sale12.9711,447148,468224,215Aug 12 05:05 PM
Schwendenman AndrewChief Accounting OfficerAug 10 '26Sale12.977,63298,98799,425Aug 12 05:04 PM
Sarchi ChristopherChief Commercial OfficerJun 01 '26Sale9.2412,000110,880180,962Jun 03 08:30 PM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.53B
IWMiShares Russell 2000 Index FundAUM: 78.30B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
IBBiShares Biotechnology ETFAUM: 11.47B
LFSCF/m Emerald Life Sciences Innovation ETFAUM: 130.49M
VXFVanguard Extended Market Index ETFAUM: 30.61B
SCHASchwab U.S. Small-Cap ETFAUM: 22.32B
DWASInvesco Dorsey Wright SmallCap Momentum ETFAUM: 393.01M
VTWOVanguard Russell 2000 Index ETFAUM: 16.97B

News

latest 14 of 206
  • Why Did ETSY, REPL, GMAB Stocks Surge To 52-Week Highs Today? (Stocktwits) +23.07% +8.28%
  • Replimune Beats On A Shrinking Loss, But The TUDRIQEV Launch Is Still Measured In Accounts, Not Revenue (Earnings Whispers)
  • Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update (GlobeNewswire)
  • Replimune's Narrowing Losses Meet A Skeptical Tape As Pipeline Clarity Takes Center Stage (Earnings Whispers)
  • Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026 (GlobeNewswire)
  • Loading…
  • Replimune Announces TUDRIQEV Now Available in the U.S. for Advanced Melanoma (GlobeNewswire)
  • Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1 (Newsfile)
  • Trump Administration Shift Puts This Corner of Biotech Back in Favor (The Wall Street Journal)
  • Replimune to Present at the Cantor Global Healthcare Conference 2026 (GlobeNewswire)
  • Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL (PR Newswire)
  • Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today? (Stocktwits)
  • Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.13%
  • Did You Lose Money Investing in Replimune Group, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About their Rights Against REPL (Newsfile) +6.49%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-10-28-0.540-0.784-0.5400.000.005
2026Q12026-08-14-0.720-0.694-0.7200.000.005
2025Q42026-06-29-0.760-0.661-0.8850.003.578
2025Q32026-02-03-0.770-0.763-0.7690.430.438
2025Q22025-11-06-0.900-0.740-0.9040.290.719
2025Q12025-08-07-0.950-0.795-0.9470.000.009
2024Q42025-05-22-0.820-0.708-0.9620.000.005
2024Q32025-02-12-0.790-0.706-0.7950.000.007
2024Q22024-11-12-0.680-0.823-0.6750.000.008
2024Q12024-08-08-0.780-0.857-0.7770.000.009
2023Q42024-05-16-0.820-0.768-0.8970.000.008
2023Q32024-02-08-0.770-0.892-0.7670.000.008
2023Q22023-11-07-0.900-0.813-0.9020.000.009
2023Q12023-08-03-0.750-0.799-0.7470.000.008
2022Q42023-05-18-0.730-0.654-0.8690.000.009
2022Q32023-02-09-0.690-0.746-0.6860.000.009

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.540-1.536-1.5360.000.00
2020FY-1.750-1.747-1.7490.000.00
2021FY-2.260-2.237-2.2610.000.00
2022FY-2.990-2.830-2.9940.000.00
2023FY-3.240-3.051-3.2420.000.00
2024FY-3.070-2.827-3.0700.002.01
2025FY-3.380-3.252-3.3800.004.38
2026FY--2.307--38.01
2027FY--1.359--187.08
2028FY-0.028--318.34
2029FY-0.938--476.53
2030FY-2.197--692.24

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-0762212.030.0025.00
2026Q3S2026-10-2872210.760.0025.00
2026Q3S2026-10-196038.240.0020.60
2026Q3S2026-10-136138.240.0020.60
2026Q3S2026-08-256238.240.0020.60
2026Q3S2026-08-196238.740.0020.60
2026Q3S2026-08-1463214.640.0047.00
2026Q3S2026-08-0653217.723.1247.00
2026Q3S2026-08-0553219.823.1247.00
2026Q3S2026-07-3151311.941.2027.00
2026Q3S2026-07-3051312.923.1227.00
2026Q3S2026-07-2952214.141.9527.00
2026Q3S2026-07-2742210.931.9525.66
2026Q3S2026-07-1942210.931.9525.66

Estimate history

EPS, annual-0.619-1.329-1.536-1.749-2.261-2.994-3.242-3.07-3.383-2.9179
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.675-0.795-0.962-0.947-0.904-0.769-0.885-0.72-0.543
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0000000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual31.84431.65736.66946.56647.33956.67661.41577.08582.71794.805
Period201720182019202020212022202320242025MRQ
Shares, quarterly68.39577.00977.08577.80778.40379.63182.71783.97994.805
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A6.576.533.502.652.454.584.141.810.15
Gross Profit-6.57-6.53-3.50-2.65-2.45-4.58-4.14-1.81-0.15
Selling, General and Administrative Excl. Other264.51314.99259.90234.04177.55116.9178.6257.4830.80
Research and Development188.02220.36191.22176.88129.4480.6457.4940.8122.17
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-271.07-321.52-263.40-236.69-179.99-121.48-82.76-59.28-30.95
Interest Expense10.978.867.896.664.162.223.061.92-
Unusual Expense0.000.000.000.000.000.000.910.005.45
Net Income Before Taxes-272.93-316.10-248.60-217.31-176.91-121.21-83.68-55.71-30.83
Income Taxes-1.89-2.15-1.30-1.51-2.63-3.17-2.81-3.080.00
Consolidated Net Income-271.03-313.94-247.30-215.79-174.28-118.04-80.87-52.62-30.83
Net Income From Continuing Operations-271.03-313.94-247.30-215.79-174.28-118.04-80.87-52.62-30.83
Net Income-271.03-313.94-247.30-215.79-174.28-118.04-80.87-52.62-30.83
EPS (Recurring)-2.58-3.38-3.07-3.24-2.99-2.26-1.73-1.54-1.16
EPS (Basic, Before Extraordinaries)-2.92-3.38-3.07-3.24-2.99-2.26-1.75-1.54-1.33
EPS (Diluted)-2.92-3.38-3.07-3.24-2.99-2.26-1.75-1.54-1.33
EBITDA-264.51-314.99-259.90-234.04-177.55-116.91-78.62-57.48-30.80
Non-Operating Income (Expense)9.1214.2922.6926.057.242.503.065.495.56
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense30.2025.4927.6826.9622.2219.168.615.652.73
Shares Outstanding94.8182.7277.0961.4256.6847.3446.5736.6731.66
Market Capitalization2,206.952,206.95750.89501.541,000.53801.621,418.52365.36481.67

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.591.751.581.651.641.670.851.00
Gross Profit-1.59-1.75-1.58-1.65-1.64-1.67-0.85-1.00
Selling, General and Administrative Excl. Other54.9366.7972.2370.5683.0389.1879.0365.39
Research and Development34.0048.9752.1852.8757.6557.6654.5348.38
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-56.52-68.54-73.80-72.21-84.67-90.84-79.88-66.39
Interest Expense3.023.092.881.982.012.001.991.98
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-57.36-70.06-73.92-71.58-83.48-87.11-74.79-66.14
Income Taxes-0.24-0.30-0.71-0.65-0.38-0.42-0.660.20
Consolidated Net Income-57.12-69.77-73.22-70.93-83.10-86.69-74.13-66.34
Net Income From Continuing Operations-57.12-69.77-73.22-70.93-83.10-86.69-74.13-66.34
Net Income-57.12-69.77-73.22-70.93-83.10-86.69-74.13-66.34
EPS (Recurring)-0.54-0.72-0.89-0.77-0.90-0.95-0.96-0.79
EPS (Basic, Before Extraordinaries)-0.54-0.72-0.89-0.77-0.90-0.95-0.96-0.79
EPS (Diluted)-0.54-0.72-0.89-0.77-0.90-0.95-0.96-0.79
EBITDA-54.93-66.79-72.23-70.56-83.03-89.18-79.03-65.39
Non-Operating Income (Expense)2.191.572.762.613.205.727.082.23
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense10.547.676.425.578.348.766.546.82
Shares Outstanding94.8183.9882.7279.6378.4077.8177.0977.01
Market Capitalization2,206.95914.08631.68762.47327.05716.14750.89912.37

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments268.89483.80420.67583.39395.65476.30168.56134.8161.55
Short Term Receivables1.623.734.922.943.062.952.962.472.39
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets8.618.358.086.285.274.492.733.700.76
Total Current Assets279.12495.88433.67592.60403.98483.75174.25140.9864.70
Net Property, Plant & Equipment48.6252.5552.3552.3555.5857.7258.2112.160.37
Total Investments and Advances1.701.701.701.641.641.641.641.190.08
Intangible Assets--0.000.000.000.000.000.000.00
Other Assets2.941.200.000.000.000.000.000.000.00
Total Assets332.39551.33487.72646.59461.19543.10234.10154.3365.15
Short Term Debt Incl. Current Port. of LT Debt4.043.983.883.763.633.463.280.000.00
Accounts Payable6.6712.462.585.363.732.353.437.081.99
Other Current Liabilities47.5245.9233.9824.7013.398.735.162.803.17
Total Current Liabilities58.2362.3640.4433.8320.7614.5511.879.885.16
Long Term Debt107.5572.1871.9957.0029.2129.8238.516.560.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.460.940.790.470.000.000.000.021.69
Total Liabilities166.23135.49113.2191.3049.9644.3750.3816.476.86
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.0086.36
Common Equity166.16415.84374.51555.29411.23498.73183.72137.86-28.07
Total Shareholders Equity166.16415.84374.51555.29411.23498.73183.72137.8658.29
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity166.16415.84374.51555.29411.23498.73183.72137.8658.29
Total Liabilities & Stockholders Equity332.39551.33487.72646.59461.19543.10234.10154.3365.15
Book Value Per Share2.015.396.109.808.6910.715.014.35-0.88
Tangible Book Value Per Share2.015.396.109.808.6910.715.014.35-0.88
Full-Time Employees4654793312842061521226743
Price to Book Ratio10.781.561.191.801.952.851.993.363.36
Return on Assets-71.05-47.60-38.05-31.47-23.51-20.81-27.10-28.10-44.79
Return on Equity-107.88-62.58-46.42-36.06-25.94-23.70-32.73-31.44-50.27
Return on Invested Capital-114.70-50.67-48.33-28.46-26.80-15.30-23.68-21.35-33.80
Quick Ratio4.797.9510.7217.5219.4633.2514.6814.2612.53
Current Ratio4.797.9510.7217.5219.4633.2514.6814.2612.53

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-271.03-313.94-247.30-215.79-174.28-118.04-80.87-52.62-30.83
Depreciation6.576.533.502.652.452.151.710.530.15
Other Funds (Non Cash)35.1630.9127.4622.1928.6626.4714.266.956.56
Funds from Operations-229.31-276.50-216.33-190.95-143.17-89.42-64.90-45.14-24.13
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-16.24-3.8424.085.4815.127.243.51-15.41-1.25
Cash from Operating Activities-245.55-280.34-192.25-185.47-128.05-82.18-61.39-60.55-25.38
Capital Expenditures-0.22-4.22-6.69-5.66-2.27-2.34-2.39-6.54-2.60
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.080.000.000.000.000.000.000.00-
Purchase or Sale of Investments221.53315.07-17.11102.86-140.230.53-186.381.31-63.34
Purchase of Investments-40.35-77.89-403.59-489.52-583.41-255.72-392.43-149.68-189.93
Sale Or Maturity of Investments261.87392.96386.48592.38443.18256.25206.05150.99126.59
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities221.38310.84-23.8097.20-142.50-1.81-188.78-5.23-65.94
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock178.2932.03253.001.76283.516.86383.5090.22101.39
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock178.2932.03253.001.76283.516.86383.5090.22101.39
Proceedsfrom Stock Options172.1531.15155.730.00187.290.00286.1161.53101.18
Issuance or Reduction of Debt, Net49.1934.26-0.6014.5227.79-0.26-10.949.940.00
Change in Long Term Debt49.1934.26-0.6014.5228.150.00-10.7910.000.00
Issuance of Long Term Debt50.0035.000.0015.0028.150.000.0010.000.00
Reduction of Long Term Debt-0.81-0.74-0.60-0.480.000.00-10.790.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities227.4866.29252.4016.28311.306.60372.46100.17101.39
Exchange Rate Effect2.221.110.32-0.09-0.110.820.72-0.14-0.84
Net Change in Cash205.5397.9136.66-72.0740.64-76.57123.0234.259.23
Free Cash Flow-245.77-284.57-198.94-191.13-130.32-84.52-63.78-67.09-27.98
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments307.83195.33268.89269.14323.64403.34
Short Term Receivables0.000.001.622.961.811.84
Inventories9.870.000.000.000.000.00
Other Current Assets6.335.488.618.268.308.19
Total Current Assets324.04200.81279.12280.35333.75413.37
Net Property, Plant & Equipment44.7346.7048.6250.3352.0052.80
Total Investments and Advances1.701.701.701.701.711.71
Other Assets3.473.242.941.201.201.20
Total Assets373.94252.45332.39333.59389.45469.51
Short Term Debt Incl. Current Port. of LT Debt4.044.044.044.084.054.04
Accounts Payable5.964.266.675.656.4015.48
Other Current Liabilities35.5630.1147.5240.3742.4540.04
Total Current Liabilities45.5538.4158.2350.0952.9059.56
Long Term Debt123.15107.94107.5572.2772.2772.29
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.460.460.460.690.940.94
Total Liabilities169.16146.80166.23123.05126.11132.79
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity204.78105.64166.16210.54263.34336.71
Total Shareholders Equity204.78105.64166.16210.54263.34336.71
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity204.78105.64166.16210.54263.34336.71
Total Liabilities & Stockholders Equity373.94252.45332.39333.59389.45469.51
Book Value Per Share2.161.262.012.643.364.33
Tangible Book Value Per Share2.161.262.012.643.364.33
Full-Time Employees--465---
Price to Book Ratio10.785.512.892.890.971.72
Return on Assets-71.01-82.28-71.05-67.19-69.91-55.79
Return on Equity-115.80-134.29-107.88-90.88-96.24-73.44
Return on Invested Capital-17.42-32.67-26.75-25.08-24.76-21.20
Quick Ratio6.905.234.795.606.316.94
Current Ratio7.115.234.795.606.316.94

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-57.12-69.77-73.22-70.93-83.10-86.69
Depreciation1.591.751.581.651.641.67
Other Funds (Non Cash)12.017.798.606.767.128.43
Funds from Operations-43.52-60.23-63.04-62.52-74.34-76.60
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-4.18-15.506.88-3.43-6.87-0.42
Cash from Operating Activities-47.70-75.73-56.16-65.95-81.21-77.02
Capital Expenditures-0.08-0.01-0.01-0.14-1.34-2.74
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.080.000.000.000.000.00
Purchase or Sale of Investments9.7650.0086.5175.2585.5167.79
Purchase of Investments0.00-9.88-3.95-26.51-9.85-37.58
Sale Or Maturity of Investments9.7659.8890.46101.7795.36105.37
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities9.7649.9986.5175.1284.1765.05
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock145.761.0020.8810.650.500.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock145.761.0020.8810.650.500.01
Proceedsfrom Stock Options141.000.0020.7810.360.000.00
Issuance or Reduction of Debt, Net14.79-0.2034.80-0.20-0.18-0.17
Change in Long Term Debt14.79-0.2034.80-0.20-0.18-0.17
Issuance of Long Term Debt15.000.0035.000.000.000.00
Reduction of Long Term Debt-0.21-0.20-0.20-0.20-0.18-0.17
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities160.550.8055.6810.450.32-0.16
Exchange Rate Effect-0.141.270.051.041.64-1.62
Net Change in Cash122.47-23.6686.0720.654.92-13.74
Free Cash Flow-47.78-75.73-56.17-66.09-82.56-79.76

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3027.60%24.6M89.2M3.48M
2026-10-1526.14%23.2M88.6M4.13M
2026-09-3026.10%23.1M88.6M4.28M
2026-09-1525.68%22.8M88.6M4.57M
2026-08-3126.89%23.5M87.5M5.01M
2026-08-1428.43%24.9M87.5M6.02M
2026-07-3134.98%27.5M78.7M6.39M
2026-07-1530.51%23.7M77.5M6.14M
2026-06-3030.53%23.7M77.5M7.81M
2026-06-1530.02%22.9M76.2M7.36M
2026-05-2934.04%26.0M76.2M6.91M
2026-05-1531.03%23.7M76.2M5.80M
2026-04-3027.80%21.2M76.1M4.58M
2026-04-1524.21%18.4M76.1M3.45M
2026-03-3121.33%16.3M76.6M1.44M
2026-03-1321.20%16.2M76.6M1.38M
2026-02-2720.73%15.9M76.6M1.41M
2026-02-1320.28%15.5M76.6M1.45M
2026-01-3020.39%15.3M75.2M1.73M
2026-01-1520.15%14.4M71.5M3.81M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.0017.0018.6017.3611.8563.001.000.985-0.1370.001
call6.0016.3017.6016.4710.48121.003.000.983-0.1370.001
call7.0015.4016.7015.2410.00821.001.000.981-0.1360.001
call7.5015.0016.1014.628.8483.001.000.979-0.1360.001
call8.0014.6015.6014.198.3855.001.000.978-0.1360.001
call8.5014.2015.2013.528.5185.001.000.977-0.1350.001
call9.0013.7014.7012.908.0879.002.000.970-0.1660.001
call9.5013.2014.2012.427.6793.004.000.969-0.1650.001
call10.0012.4013.7012.097.2953.001.000.967-0.1640.002
call10.5011.1013.2012.026.9304.004.000.965-0.1630.002
call11.0011.6012.7011.596.5848.006.000.963-0.1620.002
call11.5011.1012.2011.146.25312.007.000.961-0.1600.002
call12.0010.7011.7010.715.93712.007.000.959-0.1590.002
call12.5010.2011.2010.075.6314.003.000.957-0.1570.002
call13.009.7010.709.645.3404.005.000.954-0.1550.002
call13.507.6010.408.555.7013.000.000.952-0.1540.002
call14.008.309.708.554.7895.006.000.949-0.1520.002
call14.506.609.407.375.1172.000.000.946-0.1500.002
call15.007.208.707.694.27124.004.000.943-0.1480.002
call15.505.608.406.454.5684.000.000.939-0.1450.002
call16.006.207.706.773.78316.002.000.935-0.1430.003
call16.504.607.400.804.04835.000.000.931-0.1400.003
call17.005.306.700.253.3181.000.000.926-0.1380.003
call17.503.606.404.673.5525.000.000.921-0.1350.003
call18.004.805.705.402.8711,02020.000.915-0.1310.003
call18.502.555.403.753.07325.000.000.885-0.1690.004
call19.002.054.701.002.4380.000.000.876-0.1640.004
call19.501.504.300.002.4210.000.000.865-0.1580.004
call20.001.053.802.852.1992561000.852-0.1510.005
call20.500.504.300.002.7690.000.000.837-0.1430.005
call21.000.353.401.852.6538.000.000.816-0.1370.005
call21.500.404.300.823.0631.000.000.760-0.1600.006
call22.000.402.050.801.64524.000.000.633-0.6030.008
call22.500.901.600.501.4491.000.000.606-0.5210.008
call23.000.651.350.901.47847.0018.000.573-0.4530.008
call23.500.351.100.401.46515.000.000.532-0.3880.008
call24.000.200.850.401.4127.004.000.491-0.3670.008
call24.500.051.000.151.6362.000.000.440-0.3290.008
call25.000.200.600.201.50815.0010.000.360-0.2500.008
call25.500.004.300.001.6880.000.000.305-0.2230.007
call26.000.004.400.001.8570.000.000.277-0.2260.007
call26.500.004.400.002.0160.000.000.261-0.2380.007
call27.000.004.300.001.8410.000.000.203-0.1890.006
call27.500.004.300.002.3120.000.000.237-0.2590.006
call28.000.004.300.002.4510.000.000.228-0.2690.006
call28.500.004.300.002.5840.000.000.220-0.2770.006
call29.000.004.300.002.7120.000.000.212-0.2850.006
call29.500.004.300.002.8360.000.000.206-0.2930.006
call30.000.004.300.002.9550.000.000.200-0.3000.006
call30.500.004.300.003.0710.000.000.194-0.3060.006
call31.000.004.300.003.1830.000.000.189-0.3130.006
call31.500.004.300.003.2920.000.000.185-0.3190.005
call32.000.004.300.003.3980.000.000.181-0.3240.005
call32.500.004.300.003.5010.000.000.177-0.3300.005
call33.000.004.300.003.6020.000.000.174-0.3350.005
call33.500.004.300.003.7000.000.000.170-0.3400.005
call34.000.004.300.003.7950.000.000.167-0.3440.005
put5.000.004.300.0010.0630.000.00-0.015-0.1360.001
put6.000.004.300.008.9150.000.00-0.017-0.1360.001
put7.000.004.300.007.9500.000.00-0.019-0.1360.001
put7.500.004.300.007.5110.000.00-0.021-0.1350.001
put8.000.004.500.007.1140.000.00-0.022-0.1340.001
put8.500.000.150.005.9900.000.00-0.030-0.1220.002
put9.000.004.500.006.7930.000.00-0.030-0.1650.001
put9.500.000.250.255.70058.000.00-0.027-0.1210.001
put10.000.004.300.406.11563.000.00-0.033-0.1630.002
put10.500.004.500.005.8030.000.00-0.035-0.1620.002
put11.000.000.350.105.50516.000.00-0.037-0.1600.002
put11.500.004.300.005.2170.000.00-0.039-0.1590.002
put12.000.004.301.304.9483.000.00-0.041-0.1570.002
put12.500.004.300.374.6879.000.00-0.043-0.1560.002
put13.000.004.300.334.4357.000.00-0.046-0.1540.002
put13.500.004.301.354.1925.000.00-0.048-0.1520.002
put14.000.004.300.003.9580.000.00-0.051-0.1500.002
put14.500.004.300.003.7310.000.00-0.054-0.1480.002
put15.000.000.350.413.5101010.00-0.057-0.1460.002
put15.500.004.300.493.2971.000.00-0.061-0.1440.002
put16.000.004.300.003.0880.000.00-0.065-0.1410.003
put16.500.004.300.002.8850.000.00-0.069-0.1390.003
put17.000.004.300.532.6950.000.00-0.073-0.1350.003
put17.500.004.300.662.4915.000.00-0.079-0.1330.003
put18.000.000.200.752.3002.000.00-0.085-0.1290.003
put18.500.004.300.302.38322.000.00-0.115-0.1670.004
put19.000.001.150.602.1821.000.00-0.124-0.1610.004
put19.500.002.150.301.9834.000.00-0.135-0.1550.004
put20.000.004.300.671.7853.000.00-0.148-0.1490.005
put20.500.000.650.151.5881.000.00-0.163-0.1410.005
put21.000.003.100.701.3891.000.00-0.184-0.1340.005
put21.500.050.300.661.18821.000.00-0.240-0.1580.006
put22.000.054.000.005.2150.000.00-0.367-0.6010.008
put22.500.104.100.004.8620.000.00-0.394-0.5190.008
put23.000.304.000.004.5080.000.00-0.427-0.4500.008
put23.500.503.500.004.1510.000.00-0.468-0.3850.008
put24.000.804.200.004.6470.000.00-0.509-0.3640.008
put24.500.404.300.004.3900.000.00-0.560-0.3260.008
put25.000.954.300.004.0010.000.00-0.640-0.2470.008
put25.501.354.800.004.2110.000.00-0.695-0.2200.007
put26.001.805.000.004.0410.000.00-0.723-0.2230.007
put26.502.305.400.004.1060.000.00-0.739-0.2350.007
put27.002.805.900.004.2850.000.00-0.751-0.2460.006
put27.503.806.400.004.4560.000.00-0.763-0.2560.006
put28.004.006.900.004.6210.000.00-0.772-0.2650.006
put28.504.607.500.004.9060.000.00-0.780-0.2740.006
put29.005.108.007.085.0590.000.00-0.788-0.2820.006
put29.505.608.500.005.2070.000.00-0.794-0.2890.006
put30.006.109.000.005.3500.000.00-0.800-0.2960.006
put30.506.609.500.005.4880.000.00-0.806-0.3030.006
put31.006.7010.008.975.6220.000.00-0.811-0.3090.006
put31.507.6010.509.405.7530.000.00-0.815-0.3150.005
put32.008.1011.000.005.8790.000.00-0.819-0.3210.005
put32.508.3011.500.006.0020.000.00-0.823-0.3260.005
put33.009.3011.800.005.8570.000.00-0.826-0.3310.005
put33.509.8012.300.005.9730.000.00-0.830-0.3360.005
put34.0010.0013.0013.526.3520.000.00-0.833-0.3410.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-10SCHEDULE 13GSEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09SCHEDULE 13G/ASEC
2026-11-0610-Q/A2026-09-30SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30144Filing for proposed sale of securities under Rule 144.SEC
2026-10-28144Filing for proposed sale of securities under Rule 144.SEC
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-09-168-KCurrent report2026-09-15SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-14S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-11SCHEDULE 13D/ASEC
2026-08-118-K/A2026-08-09SEC
2026-08-108-KCurrent report2026-08-09SEC
2026-08-10424B5SEC
2026-08-10SCHEDULE 13GSEC
2026-08-078-KCurrent report2026-08-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100521.86K2
2026-100000
2026-090000
2026-08001.04M5
2026-070000
2026-0600110.88K1
2026-0500474.15K6
2026-040052.07K1
2026-030000
2026-020000
2026-010000
2025-1200144.26K2
2025-1100113.35K2

Institutional holders

Manager% owned
BAKER BROS. ADVISORS LP13.38%
BlackRock, Inc.10.85%
RTW INVESTMENTS, LP8.98%
Ridgeback Capital Investments L.P.8.85%
GOLDMAN SACHS GROUP INC5.50%
STATE STREET CORP5.38%
MONTANOVA CAPITAL, LLC5.32%
Boxer Capital Management, LLC4.82%
VANGUARD CAPITAL MANAGEMENT LLC3.51%
FCPM III SERVICES B.V.3.40%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF3.34%
iShares Russell 2000 ETF2.51%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.39%
VANGUARD EXTENDED MARKET INDEX FUND1.03%
Fidelity Small Cap Index Fund1.03%
iShares Russell 2000 Value ETF0.89%
T. Rowe Price New Horizons Fund, Inc.0.87%
Artisan International Small-Mid Fund0.73%
Emerald Growth Fund0.66%
iShares Biotechnology ETF0.65%

OakChart. REPL. Cached 15 minutes.